CAS: 2098225-93-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Budigalimab REF: TM-T76936CAS: 2098225-93-3 | 95% - 95% | 206.00 €~1,632.00 € | Tue 21 Jan 25 |
 | Budigalimab REF: 3D-CLA1527CAS: 2098225-93-3 | - - - | To inquire | Fri 31 Jan 25 |
Budigalimab
CAS:2098225-93-3
Budigalimab (ABBV 181) is a humanized monoclonal antibody targeting PD-1 with potential antitumor activity.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76936
| 1mg | 206.00 € | ||
| 5mg | 527.00 € | ||
| 10mg | 846.00 € | ||
| 25mg | 1,257.00 € | ||
| 50mg | 1,632.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 3D-CLA1527
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 31 Jan 2025
